Levels of antibodies targeting the Epstein-Barr virus are not associated with disease activity among multiple sclerosis ...

A small cohort of individuals diagnosed with MS early in life had a significant employment-related impact that was associated ...

Discover how wearable technology is changing the understanding of MS through real-time brain function tracking and analysis ...

MOG-IgG positivity is rare in MS patients, complicating diagnosis and treatment, especially in Asian populations with lower ...

A biology teacher and mother-of-two has become the first UK patient to receive a "gamechanger" therapy to treat multiple ...

Emily Henders received her CAR T last week at University College London Hospital (UCLH) as part of a global clinical trial ...

People with MS of all ages and genders consistently report reduced quality of life relative to the general population, a ...

A study using wearable scanning technology has revealed how brain function differs in people with multiple sclerosis (MS). It ...

A multiple sclerosis (MS) patient in the UK was the first to receive CAR T cell therapy, invented by UCL researchers, in a ...

Discover how CAR T cell therapy is breaking new ground in treating Multiple Sclerosis for the first time in the UK ...

A biology teacher has become the first patient in the UK to receive “gamechanger” therapy to treat multiple sclerosis.

"Multiple sclerosis: three trials to watch" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.